Staff

Nerea Vega García

Search publications

Publications

  • Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garcés C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, José Luis Dapena Díaz, Rives-Sola S, Ramirez M and Camós-Guijosa M.

    Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

    Frontiers in pediatrics . 8: 614521-614521. Number of citations: 2

    [doi:10.3389/fped.2020.614521]

  • Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garcés C, Alonso J, Barragán E, Fernández G, Hernández-Sánchez JM, Martín-Izquierdo M, Joan Maynou Fernández, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Sola S, Dapena JL, Ramírez M and Camós-Guijosa M.

    Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia.

    Journal of Personalized Medicine . 10(4): 244. Number of citations: 1

    [doi:10.3390/jpm10040244]

  • Montano, A, Matorra-Miguel, M, Forero-Castro, M, Lumbreras, E, Santos, S, Miguel, C, Fuster, JL, De las Heras, N, Garcia-de Coca, A, Sierra, M, Davila, J, De la Fuente, I, Olivier, C, Olazabal, J, Martinez, J, Vega-García N, Camós-Guijosa M, Gonzalez, T, Hernandez-Rivas, JM and Benito, R.

    APPLICATION OF A NGS DIAGNOSTIC PANEL TO IMPROVE AND REFINE THE STRATIFICATION OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA B

    HAEMATOLOGICA . 105: 26-26.

  • Montaño A, Hernández-Sánchez J, Forero-Castro M, Matorra-Miguel M, Lumbreras E, Miguel C, SUSANA SANTOS RUÍZ, Ramírez-Maldonado V, Fuster JL, de Las Heras N, García-de Coca A, Sierra M, Dávila J, de la Fuente I, Olivier C, Olazabal J, Martínez J, Vega-García N, González T, Hernández-Rivas JM and Benito R.

    Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.

    Journal of Personalized Medicine . 10(3): 137.

    [doi:10.3390/jpm10030137]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia.

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Number of citations: 3

    [doi:10.1016/j.phrs.2019.104556]

  • Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue Meda M, Pont-Martí S, Rives-Sola S and Camós-Guijosa M.

    Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.

    BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553. Number of citations: 3

    [doi:10.1111/bjh.15436]

  • Català-Temprano A, Pastor-Anglada M, Caviedes-Cárdenas L, Malatesta R, Rives-Sola S, Vega-García N, Camós-Guijosa M and Fernández-Calotti P.

    FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.

    Oncotarget . 7(31): 49786-49799. Number of citations: 9

    [doi:10.18632/oncotarget.10448]

  • Vega-García N, Malatesta R, Rives-Sola S, Català-Temprano A, Berrueco R, Torrebadell-Burriel M, Estella-Aguado MC, Barneda-Zahonero B, Alonso-Saladrigues A, Trabazo-del Castillo M, Ruiz-Llobet A, Parra-Bola M, Bigas-Salvans A and Camós-Guijosa M.

    THE PATTERN OF EXPRESSION OF HISTONE DEACETYLASE (HDAC) IS ASSOCIATED WITH POOR PROGNOSTIC FACTORS IN ACUTE PAEDIATRIC LEUKEMIA

    HAEMATOLOGICA . 100: 138-139.

  • Barneda-Zahonero B, Collazo O, Azagra A, Fernández-Duran I, Serra-Musach J, Islam AB, Vega-García N, Malatesta R, Camós-Guijosa M, Gómez A, Román-González L, Vidal A, López-Bigas N, Villanueva A, Esteller M and Parra M.

    The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma

    CELL DEATH & DISEASE . 6: 1635. Number of citations: 28

    [doi:10.1038/cddis.2014.594]

  • Bueno C, Barrena S, Bataller A, Ortiz-Maldonado V, Elliott N, O'Byrne S, Wang G, Rovira M, Gutierrez-Agüera F, Trincado JL, Gonzalez M, Morgades M, Sorigué M, Barcena P, Zanetti SR, Torrebadell-Burriel M, Vega-García N, Rives-Sola S, Mallo M, Sole F, Mead AJ, Roberts I, Thongjuea S, Psaila B, Manel Juan Otero, Delgado J, Urbano-Ispizua Á, Ribera JM, Orfao A, Roy A and Menéndez P.

    CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies.

    Blood . : .

    [doi:10.1182/blood.2021014840]